Barings’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-6,100
Closed -$273K 712
2018
Q4
$273K Sell
6,100
-21,100
-78% -$1.11M ﹤0.01% 606
2018
Q3
$1.86M Buy
27,200
+21,100
+346% +$1.36M 0.03% 363
2018
Q2
$349K Hold
6,100
﹤0.01% 724
2018
Q1
$281K Hold
6,100
﹤0.01% 826
2017
Q4
$282K Hold
6,100
﹤0.01% 849
2017
Q3
$275K Hold
6,100
﹤0.01% 777
2017
Q2
$240K Sell
6,100
-6,100
-50% -$230K 0.01% 780
2017
Q1
$464K Buy
12,200
+6,100
+100% +$238K 0.01% 944
2016
Q4
$226K Hold
6,100
0.01% 824
2016
Q3
$211K Buy
+6,100
New +$214K 0.01% 754
2016
Q1
Sell
-6,100
Closed -$204K 938
2015
Q4
$204K Sell
6,100
-118,975
-95% -$3.7M 0.01% 874
2015
Q3
$3.56M Buy
125,075
+1,400
+1% +$48.8K 0.09% 163
2015
Q2
$5.01M Sell
123,675
-32,309
-21% -$1.45M 0.15% 136
2015
Q1
$7.67M Buy
+155,984
New +$7.23M 0.18% 76

Other funds holding AVNS

Barings's AVNS Position: Q1 2019 in Review

Barings sold out of Avanos Medical (AVNS) in Q1 2019, closing a stake of 6,100 shares — an estimated $273K sold.

Barings first reported a position in AVNS in Q1 2015 and held it in 14 quarters. The position peaked at $7.67M in Q1 2015. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2019.

  • Barings reported no remaining Avanos Medical position as of Q1 2019 after selling out during the quarter.
  • Barings sold 6,100 Avanos Medical shares in Q1 2019, an estimated $273K.
  • Barings first reported a position in Avanos Medical in Q1 2015 and held it in 14 quarters.
  • Barings's Avanos Medical position peaked at $7.67M in Q1 2015.
  • 338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2019.

Based on Barings's 13F filing for Q1 2019, filed 8 May 2019.